Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer

Prostate cancer is generally considered an immunologically “cold” tumor type that is insensitive to immunotherapy. Targeting surface antigens on tumors through cellular therapy can induce a potent antitumor immune response to “heat up” the tumor microenvironment. However, many antigens expressed on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanvit, Peter, van Dyk, Dewald, Fazenbaker, Christine, McGlinchey, Kelly, Luo, Weichuan, Pezold, Jessica M., Meekin, John, Chang, Chien-ying, Carrasco, Rosa A., Breen, Shannon, Cheung, Crystal Sao-Fong, Endlich-Frazier, Ariel, Clark, Benjamin, Chu, Nina J., Vantellini, Alessio, Martin, Philip L., Hoover, Clare E., Riley, Kenesha, Sweet, Steve M., Chain, David, Kim, Yeoun Jin, Tu, Eric, Harder, Nathalie, Phipps, Sandrina, Damschroder, Melissa, Gilbreth, Ryan N., Cobbold, Mark, Moody, Gordon, Bosco, Emily E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645390/
https://www.ncbi.nlm.nih.gov/pubmed/37966111
http://dx.doi.org/10.1172/JCI169655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645390/
https://www.ncbi.nlm.nih.gov/pubmed/37966111
http://dx.doi.org/10.1172/JCI169655

Ejemplares similares